Delivery Order SPE2DB24D3014-SPE2DB24FKSCJ
Award Date
8/29/24
Potential Completion Date
8/30/24
Potential Value
$6.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $15,685.92 firm fixed-price delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of September 3, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
This federal contract award is a delivery order valued at $7,311.53 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, with a performance period through May 22, 2025. Amerisourcebergen Drug Corp is the prime contractor on this non-set-aside contract. This award is associated with Amerisourcebergen's broader Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $9,542.57 firm-fixed-price delivery order is for the supply of 4566064167 - VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of October 10, 2024 and was awarded on October 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of 4564882109 - VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $11,940.21, is a Firm Fixed Price Delivery Order with a completion date of June 12, 2024. Amerisourcebergen, as a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery...
This federal contract award, issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,625.35 firm fixed-price delivery order is to provide VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,632.13 firm fixed-price delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of November 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of VRAYLAR 1.5 MG CAPSULE 30S. The contract, valued at $4,377.75, is a firm fixed-price delivery order with a completion date of July 19, 2024. The contract is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $8,154.96, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corporation. The contract is for the delivery of 4566358010 - VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 7, 2024. Amerisourcebergen Drug Corporation is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award, valued at $5,318.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. This is a firm-fixed-price delivery order contract with a completion date of September 20, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,138.39, is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S. It is a Firm Fixed Price Delivery Order with an ultimate completion date of April 14, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...